Advisor Group Holdings, Inc. Ardelyx, Inc. Transaction History
Advisor Group Holdings, Inc.
- $42.2 Billion
- Q3 2024
A detailed history of Advisor Group Holdings, Inc. transactions in Ardelyx, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 11,712 shares of ARDX stock, worth $60,551. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,712
Previous 7,097
65.03%
Holding current value
$60,551
Previous $52,000
53.85%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding ARDX
# of Institutions
218Shares Held
141MCall Options Held
1.08MPut Options Held
2M-
Janus Henderson Group PLC London, X021.5MShares$111 Million0.08% of portfolio
-
Black Rock Inc. New York, NY17.6MShares$90.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.6MShares$70.3 Million0.0% of portfolio
-
State Street Corp Boston, MA12.1MShares$62.8 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C38.95MShares$46.3 Million0.07% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $799M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...